Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

Glycogen storage disease type 1a (von Gierke ... Blood biochemistry showed hyperlipoproteinemia and hyperuricemia. A fasting glucagon test resulted in a flat blood glucose curve.

These mice exhibit symptoms of obesity and diabetes at approximately 5 weeks after birth, followed by degranulation and glycogen degeneration of islet cells, cell hypertrophy, cell vacuolization, and ...

This deadly duo triggers the buildup of glycogen, stored sugar, in lung tissue, creating what researchers call a “giant lollipop for cancer’s sweet tooth.” Research published in Nature Metabolism ...

According to Monday’s news release, the candidate, OPK-88006, is set to be the first oral GLP-1/glucagon agonist to start human studies. Under the terms of the agreement, OPKO and Entera will split ...

Gvoke VialDx has the potential to modernize the handling and administration of glucagon for diagnostic procedures,” said Kevin McCulloch, President and COO of Xeris. “American Regent is the ...

Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first orally administered dual agonist glucagonlike-peptide 1 (GLP-1)/glucagon peptide into the clinic.

Insufficient hepatic stores of glycogen may be present in conditions ... has been reported post-marketing following continuous glucagon infusion and resolved with discontinuation of the glucagon.